Medicine

Engineered insulin that can be activated by high blood sugar could improve diabetics’ quality of life.

An international Yale-led research team has shown that a risk profile based on 52 genes accurately predicts survival for patients with a severe lung disease.

Bacterial populations in mother’s GI tract may play a central role.

Roche announced today that the first data on a novel blood-based assay, co-developed with Foundation Medicine (NASDAQ: FMI), will be presented during the European Society for Medical Oncology (ESMO) Congress from 8-12 September 2017 in Madrid, Spain

3D-printed structures that degrade on command could be used to make lab-on-a-chip devices or, in the future, scaffolding for artificial tissues.

LabCorp® (NYSE: LH), a leading global life sciences company, has been named to Forbes’ 2017 ranking of “The World’s Most Innovative Companies.” 

Sanofi announced today that the European ratings agency Scope Ratings AG (“Scope”) assigned the company a AA long term rating and a S-1+ short-term rating. The outlook is stable

Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer

Scientists thought glia in the brain were just passive support cells. They may have a bigger role than once thought—contributing to the creation of neurons.

Santhera Announces Financial Results for the First Half-Year 2017 and Reports Commercial and Development Progress

Novartis landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS

Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.

Sonova appoints Arnd Kaldowski as new CEO and successor of Lukas Braunschweiler

Yamaha Motor Co., Ltd. (Tokyo:7272) announced today that it has developed the Cell Picking & Imaging System CELL HANDLERTM